Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332580![]() ((2E)-1-{2-[(2E)-3-(3,4-dichlorophenyl)prop-2-enoyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332546![]() ((2E)-1-{7-[(2E)-3-(4-bromophenyl)prop-2-enoyl]-2,7...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332555![]() ((2E)-1-{2-[(3,5-dichlorophenyl)carbonyl]-2,7-diaza...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332614![]() (3-(4-bromophenyl)-1-{2-[(4-chlorophenyl)methyl]-2,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332636![]() (3-(4-chlorophenyl)-1-{7-[(4-methoxyphenyl)carbonyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332641![]() (3-(4-fluorophenyl)-1-(7-{[4-(trifluoromethyl)pheny...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332646![]() (5-bromoindol-2-yl 7-{[4-(trifluoromethyl)phenyl]ca...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332550![]() (5-chloroindol-2-yl 2-[(4-fluorophenyl)carbonyl]-2,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332567![]() ((2E)-3-(4-bromophenyl)-1-(7-{[4-fluoro-3-(trifluor...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332588![]() (4-({2-[(2E)-3-(4-bromophenyl)prop-2-enoyl]-2,7-dia...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332589![]() ((2E)-1-{7-[(3,5-difluorophenyl)carbonyl]-2,7-diaza...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332616![]() (3-(4-bromophenyl)-1-(2-{[4-(trifluoromethyl)phenyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332618![]() (3-(4-bromophenyl)-1-(2-{[4-(trifluoromethyl)phenyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332624![]() (3-(4-chlorophenyl)-1-(2-{[4-(trifluoromethyl)pheny...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332648![]() ((2E)-3-(4-bromophenyl)-1-{2-[(4-chlorophenyl)carbo...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332552![]() ((2E)-3-(4-bromophenyl)-1-[2-(phenylcarbonyl)-2,7-d...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332557![]() ((2E)-3-(4-bromophenyl)-1-{2-[(3-methylphenyl)carbo...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332575![]() ((2E)-3-(3,4-dichlorophenyl)-1-(7-{[4-(trifluoromet...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332598![]() ((2E)-3-(4-bromophenyl)-1-{2-[(4-fluorophenyl)carbo...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332633![]() (3-(4-fluorophenyl)-1-(2-{[4-(trifluoromethyl)pheny...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332547![]() ((2E)-3-(4-bromophenyl)-1-{7-[(3-bromophenyl)carbon...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332562![]() (5-chloroindol-2-yl 2-[(4-fluorophenyl)methyl]-2,7-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332565![]() ((2E)-3-(4-bromophenyl)-1-{7-[(4-fluorophenyl)carbo...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332574![]() ((2E)-3-(3,4-dichlorophenyl)-1-{7-[(4-chlorophenyl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332585![]() (5-chloroindol-2-yl 7-[(4-chlorophenyl)carbonyl]-2,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332591![]() (5-bromoindol-2-yl 7-[(4-bromophenyl)carbonyl]-2,7-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332597![]() ((2E)-3-(4-bromophenyl)-1-(2-{[4-fluoro-2-(trifluor...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332625![]() (3-(4-chlorophenyl)-1-(7-{[4-(trifluoromethyl)pheny...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332629![]() (3-(4-chlorophenyl)-1-{7-[(4-chlorophenyl)carbonyl]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332632![]() (1-{2-[(4-chlorophenyl)carbonyl]-2,7-diazaspiro[3.5...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332553![]() ((2E)-3-(4-bromophenyl)-1-{2-[(4-fluorophenyl)methy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332556![]() ((2E)-1-{2-[(2,6-dichlorophenyl)methyl]-2,7-diazasp...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332564![]() ((2E)-3-(4-bromophenyl)-1-{7-[(4-chlorophenyl)carbo...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332573![]() ((2E)-3-(3,4-dichlorophenyl)-1-{7-[(4-fluorophenyl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332584![]() (5-chloroindol-2-yl 7-{[4-(trifluoromethyl)phenyl]c...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332593![]() (5-bromoindol-2-yl 7-{[4-fluoro-2-(trifluoromethyl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332613![]() (3-(4-bromophenyl)-1-{2-[(4-fluorophenyl)methyl]-2,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332617![]() (3-(4-bromophenyl)-1-{2-[(4-bromophenyl)methyl]-2,7...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332619![]() (3-(4-bromophenyl)-1-{2-[(4-methoxyphenyl)carbonyl]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332622![]() (3-(4-chlorophenyl)-1-{2-[(4-fluorophenyl)carbonyl]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332554![]() ((2E)-1-{2-[(3,4-dimethoxyphenyl)carbonyl]-2,7-diaz...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332563![]() (5-chloroindol-2-yl 7-{[3-fluoro-4-(trifluoromethyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332621![]() (3-(4-chlorophenyl)-1-{2-[(4-chlorophenyl)carbonyl]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332623![]() (3-(4-chlorophenyl)-1-(2-{[4-(trifluoromethyl)pheny...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332645![]() (5-chloroindol-2-yl 9-{[3-fluoro-4-(trifluoromethyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332549![]() (5-chloroindol-2-yl 2-[(3-fluorophenyl)methyl]-2,7-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332551![]() ((2E)-3-(4-bromophenyl)-1-{2-[(4-chlorophenyl)methy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332566![]() ((2E)-3-(4-bromophenyl)-1-(7-{[4-(trifluoromethyl)p...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332590![]() ((2E)-3-(4-bromophenyl)-1-(7-{[4-fluoro-2-(trifluor...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332596![]() ((2E)-1-{7-[(4-aminophenyl)carbonyl]-2,7-diazaspiro...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332599![]() ((2E)-3-(4-bromophenyl)-1-(2-{[4-(trifluoromethyl)p...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332627![]() (3-(4-chlorophenyl)-1-{2-[(4-chlorophenyl)methyl]-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332640![]() (1-{7-[(4-bromophenyl)carbonyl]-2,7-diazaspiro[3.5]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332548![]() (3-(4-chlorophenyl)-1-{7-[(4-fluorophenyl)carbonyl]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332630![]() (3-(4-chlorophenyl)-1-{7-[(4-chlorophenyl)methyl]-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332570![]() ((2E)-3-(4-bromophenyl)-1-{7-[(4-fluorophenyl)methy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332579![]() ((2E)-3-(3,4-dichlorophenyl)-1-(7-{[3-fluoro-4-(tri...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332583![]() (5-chloroindol-2-yl 7-[(4-fluorophenyl)carbonyl]-2,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332615![]() (3-(4-bromophenyl)-1-{2-[(4-chlorophenyl)carbonyl]-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332558![]() (5-chloroindol-2-yl 2-{[3-fluoro-4-(trifluoromethyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332578![]() ((2E)-3-(3,4-dichlorophenyl)-1-{7-[(4-chlorophenyl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332568![]() ((2E)-3-(4-bromophenyl)-1-{7-[(4-(1H-1,2,3,4-tetraa...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332606![]() (6-bromoindol-2-yl 7-{[4-fluoro-2-(trifluoromethyl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332569![]() ((2E)-1-(7-{[3,5-bis(trifluoromethyl)phenyl]methyl}...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332639![]() (1-{7-[(4-chlorophenyl)carbonyl]-2,7-diazaspiro[3.5...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332635![]() (3-(4-fluorophenyl)-1-(2-{[4-fluoro-2-(trifluoromet...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332626![]() (3-(4-chlorophenyl)-1-{7-[(4-fluorophenyl)methyl]-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332620![]() (3-(4-bromophenyl)-1-{2-[(4-methoxyphenyl)methyl]-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332611![]() (3-(4-bromophenyl)-1-{2-[(4-bromophenyl)carbonyl]-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332609![]() (3-(4-bromophenyl)-1-{7-[(4-chlorophenyl)carbonyl]-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332571![]() ((2E)-3-(4-bromophenyl)-1-{7-[(4-chlorophenyl)methy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332610![]() (3-(4-bromophenyl)-1-(7-{[4-(trifluoromethyl)phenyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332592![]() (5-bromoindol-2-yl 7-[(4-fluorophenyl)carbonyl]-2,7...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332631![]() (3-(4-fluorophenyl)-1-{2-[(4-fluorophenyl)carbonyl]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332582![]() (4-(2-(5-chloro-1H-indole-2-carbonyl)-2,7-diazaspir...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332581![]() (5-chloroindol-2-yl 7-{[4-(trifluoromethoxy)phenyl]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332577![]() ((2E)-3-(3,4-dichlorophenyl)-1-{7-[(4-fluorophenyl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332560![]() (5-chloroindol-2-yl 2-{[4-(trifluoromethyl)phenyl]m...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332644![]() (1-{2-[(4-bromophenyl)carbonyl]-2,7-diazaspiro[3.5]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332559![]() (5-chloroindol-2-yl 2-{[3-fluoro-4-(trifluoromethyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332572![]() ((2E)-3-(4-bromophenyl)-1-(7-{[4-fluoro-3-(trifluor...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332607![]() (7-[(3,5-dimethoxyphenyl)methyl]-2,7-diazaspiro[3.5...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332637![]() (3-(4-fluorophenyl)-1-{7-[(4-methoxyphenyl)carbonyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332642![]() (3-(2,4-difluorophenyl)-1-{7-[(4-methoxyphenyl)carb...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332643![]() (3-(2H-benzo[3,4-d]1,3-dioxolen-5-yl)-1-{2-[(4-chlo...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332634![]() (3-(4-fluorophenyl)-1-{2-[(4-methoxyphenyl)carbonyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332638![]() (3-(4-fluorophenyl)-1-{7-[(4-fluorophenyl)carbonyl]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332605![]() (5-bromoindol-2-yl 7-{[4-fluoro-2-(trifluoromethyl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332594![]() (5-bromoindol-2-yl 7-[(4-chlorophenyl)methyl]-2,7-d...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332647![]() (US10196369, Compound H1 | tert-butyl 7-(3-(benzo[d...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332595![]() (5-bromoindol-2-yl 7-{[4-(trifluoromethyl)phenyl]me...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332608![]() (6-bromoindol-2-yl 7-{[4-(trifluoromethyl)phenyl]me...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332604![]() (6-bromoindol-2-yl 7-[(4-chlorophenyl)carbonyl]-2,7...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332602![]() (6-bromoindol-2-yl 7-[(4-fluorophenyl)carbonyl]-2,7...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332600![]() (6-chloroindol-2-yl 7-[(4-fluorophenyl)carbonyl]-2,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332603![]() (6-bromoindol-2-yl 7-{[4-(trifluoromethyl)phenyl]ca...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332628![]() (3-(4-chlorophenyl)-1-(7-{[4-(trifluoromethyl)pheny...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332601![]() (6-chloroindol-2-yl 7-[(4-chlorophenyl)carbonyl]-2,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332582![]() (4-(2-(5-chloro-1H-indole-2-carbonyl)-2,7-diazaspir...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332587![]() (5-chloroindol-2-yl 7-[(4-(1H-1,2,3,4-tetraazol-5-y...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332561![]() (5-chloroindol-2-yl 2-[(4-(1H-1,2,3,4-tetraazol-5-y...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332612![]() (3-(4-bromophenyl)-1-{2-[(4-fluorophenyl)carbonyl]-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332576![]() ((2E)-3-(3,4-dichlorophenyl)-1-{7-[(4-(1H-1,2,3,4-t...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair |